Pregnancy

Evvy Announces the Company’s First Chief Medical Officer and Publishes Peer-Reviewed Validation on the Evvy Vaginal Health Test, Advancing its Mission of Unlocking Precision Female Healthcare

Travere Therapeutics and CSL Vifor Announce Swissmedic Approval of FILSPARI® (sparsentan) for the Treatment of IgA Nephropathy

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT TrialSAN DIEGO, Oct....

Veru to Deliver Keynote Presentation on the Scientific Support for Enobosarm in Combination with GLP-1 Receptor Agonist to Preserve Muscle for Higher Quality Weight Loss at the 4th Edition of the World Obesity and Weight Management Congress

Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers

First-of-its-kind service empowers discreet and more convenient access to testing and treatment for vaginitis and similar genital tract infections such...

Marani Health and Ouma Health Secure $5 Million CDC Grant with the University of Wisconsin-Madison to Fund Critical Maternal and Child Health Research

CDC Grant will enable new research addressing maternal and child health racial disparities in Wisconsin.  ST. PAUL, Minn. and AUSTIN,...

Guardian launches GuardianWell™, a new digital hub designed to enhance benefits utilization and inspire well-being®

With half of employers looking to improve workforce understanding of benefits, GuardianWell will enhance benefits utilization by offering relevant wellness...

Reunion Neuroscience Partners with Seleni Institute on Effective Diagnosis and Treatment of Maternal Mental Health Disorders

Reunion to Sponsor Scholarships that will Train Healthcare Professionals on Maternal Mental Health Disorders, including Postpartum Depression Reunion’s Phase 2...

Maven Clinic Announces $125 Million Series F Round of Funding to Chart the Next Decade of Innovation in Women’s and Family Health

New funds will fuel growth of Maven's end-to-end platform, with a focus on scaling its fertility & family building program,...

GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery disease

GE HealthCare’s FDA-approved flurpiridaz F 18 PET radiotracer, Flyrcado, delivers higher diagnostic efficacy in patients with known or suspected coronary...

Dupixent® (dupilumab) Approved in China as the First-ever Biologic Medicine for Patients with Chronic Obstructive Pulmonary Disease (COPD)

Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark...

error: Content is protected !!